XML 42 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation - Summary of Stock Based Compensation Grants (Details)
shares in Thousands
9 Months Ended
Nov. 03, 2018
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Balance at beginning of year, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 50.51
Granted, Weighted Average Exercise Price (in dollars per share) | $ / shares 0
Exercised/vested, Weighted Average Exercise Price (in dollars per share) | $ / shares 50.46
Forfeited/expired, Weighted Average Exercise Price (in dollars per share) | $ / shares 53.38
Balance at end of quarter, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 51.87
Balance at beginning of year, shares | shares 1,139
Granted, shares | shares 0
Exercised/vested, shares | shares (992)
Forfeited/expired, shares | shares (2)
Balance at end of quarter, shares | shares 145
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]  
Balance at beginning of year, Weighted Average Grant Date Fair Value | $ / shares $ 45.60
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares 63.57
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares 47.56
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares 48.78
Balance at end of quarter, Weighted Average Grant Date Fair Value | $ / shares $ 51.62
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares 2,811
Granted, shares | shares 1,017
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares (1,102)
Forfeited/expired performance restricted share units | shares (78)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares 2,648
Performance Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]  
Balance at beginning of year, Weighted Average Grant Date Fair Value | $ / shares $ 44.97
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares 65.71
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares 78.35
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares 46.91
Balance at end of quarter, Weighted Average Grant Date Fair Value | $ / shares $ 48.21
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares 660
Granted, shares | shares 187
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares (38)
Forfeited/expired performance restricted share units | shares (5)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares 804